The Survival Benefit of Chemoradiotherapy following Induction Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Unresectable Locally Advanced Pancreatic Cancer

SIMPLE SUMMARY: An optimal therapeutic strategy for unresectable locally advanced pancreatic cancer (UR-LAPC) has not been established. The aim of this retrospective study was to evaluate the therapeutic efficacy, progression-free survival (PFS), and overall survival (OS) of patients with UR-LAPC wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Takada, Ryoji, Ikezawa, Kenji, Daiku, Kazuma, Maeda, Shingo, Abe, Yutaro, Urabe, Makiko, Kai, Yugo, Yamai, Takuo, Fukutake, Nobuyasu, Nakabori, Tasuku, Uehara, Hiroyuki, Ashida, Reiko, Akita, Hirofumi, Takahashi, Hidenori, Teshima, Teruki, Ohkawa, Kazuyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470784/
https://www.ncbi.nlm.nih.gov/pubmed/34572960
http://dx.doi.org/10.3390/cancers13184733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470784/
https://www.ncbi.nlm.nih.gov/pubmed/34572960
http://dx.doi.org/10.3390/cancers13184733

Ejemplares similares